Journal
Neurology
Method of Research
Experimental study
Subject of Research
People
Article Title
Combined regulatory T-lymphocyte and IL-2 treatment is safe, tolerable, and biologically active for 1 year in persons with amyotrophic lateral sclerosis
Article Publication Date
1-Nov-2022